New setback for the arrival of the first Alzheimer's drugs in the State
For a year now, Europe has had two approved drugs to slow the progression of Alzheimer's, but Catalan patients have not yet been able to benefit from them because they are not yet authorized in…
Read the full articleYou might also wanna read
India Launches First Alzheimer’s Therapy: A New Hope for Early-Stage Patients
For millions of families around the world, Alzheimer’s disease has long come with one painful truth: treatments could only help control symp
Experimental drug takes a new aim at Alzheimer’s, with promising early results
For years, scientists have struggled to crack one of Alzheimer’s biggest mysteries. That may finally be changing.
Experimental drug takes a new aim at Alzheimer’s, with promising early results
For years, scientists have struggled to crack one of Alzheimer’s biggest mysteries. That may finally be changing.
Experimental drug takes a new aim at Alzheimer’s, with promising early results
For years, scientists have struggled to crack one of Alzheimer’s biggest mysteries. That may finally be changing.
Experimental drug takes a new aim at Alzheimer’s, with promising early results
For years, scientists have struggled to crack one of Alzheimer’s biggest mysteries. That may finally be changing.
The costly failure of amyloid-beta drugs: A cautionary tale in pharmaceutical development
2.8k words, 12 minute reading time
owlposting.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.